Table 1.
Epidemiologic association of self-reported long sleep with mortality
Citation | Population studied (1. N, 2. Ages, 3. Years Study Duration) |
Number of covariates besides age |
Age-adjusted mortality rates RR: Relative Risk (95% confidence interval, when available) |
Mortality rates adjusted for all covariates RR: Relative Risk (95% confidence interval) |
||
---|---|---|---|---|---|---|
Amagai et al.18 |
|
8 | RR (ref 7–7.9 h; men, women) <6h: 2.3 (1.3, 3.9), 0.8 (0.3, 2.2) 6–6.9h: 1.1 (0.7, 1.8), 1.3 (0.8, 2.0) 7–7.9h: 1.0, 1.0 8–8.9h: 1.0 (0.7, 1.3), 1.0 (0.7, 1.5) >=9h: 1.3 (0.9, 1.8), 1.5 (1.0, 2.3) |
RR (ref 7–7.9 h; men, women) <6h: 2. 4 (1.3, 4.2), 0.7 (0.2, 2.3) 6–6.9h: 1.1 (0.7, 1.8), 1. 3 (0.8, 2.1) 7–7.9h: 1,0, 1.0 8–8.9h: 0.9 (0.6, 1.2), 1. 1 (0.8, 1.6) >=9h: 1.1 (0.8, 1.6), 1.5 (1.0, 2.4) |
||
Ayas et al.42 |
|
15 | Fatal Coronary Heart Disease RR (Ref 8 h) <=5h: 1.67 (1.02–2.74) 6h: 1.05 (0.75–1.46) 7h: 0.80 (0.58–1.09) 8h: 1.00 >=9h: 1.71 (1.05–2.77) |
Fatal Coronary Heart Disease RR (Ref 8 h) <=5h: 1.12 (0.68–1.84) 6h: 0.91 (0.65–1.28) 7h: 0.83 (0.60–1.14) 8h: 1.00 >=9h: 1.45 (0.89–2.36) |
||
Breslow & Enstrom19 |
|
0 | Mortality Rates | |||
Women | Men | |||||
<=6h: 0.097 | 0.156 | |||||
7h: 0.068 | 0.115 | |||||
8h: 0.084 | 0.111 | |||||
>=9h: 0.104 | 0.139 | |||||
Burazeri et al.9 |
|
24 | All-Cause Mortality Night Sleep RR (ref 6h) |
All-Cause Mortality Night Sleep RR (ref 6h) |
||
Women | Men | Women | Men | |||
<6h: 1.00 | 1.00 | <6h: 1.00 | 1.00 | |||
6–8h: 0.82 | 1.21 | 6–8h: 0.80 | 1.25 | |||
(0.57–1.17) | (0.83–1.76) | (0.54–1.17) | (0.83–1.87) | |||
>8h: 0.95 | 1.86 | >8h: 1.08 | 1.91 | |||
(0.63–1.42) | (1.19–2.91) | (0.70–1.66) | (1.16–3.13) | |||
Night Sleep + Napping RR (ref 6h) |
Night Sleep + Napping RR (ref 6h) |
|||||
Women | Men | Women | Men | |||
<6h: 1.00 | 1.00 | <6h: 1.00 | 1.00 | |||
6–8h: 0.68 | 1.03 | 6–8h: 0.64 | 1.41 | |||
(0.46–1.01) | (0.65–1.64) | (0.42–0.97) | (0.83–2.39) | |||
>8h: 0.84 | 1.81 | >8h: 0.80 | 2.13 | |||
(0.56–1.27) | (1.12–2.93) | (0.51–1.24) | (1.23–3.71) | |||
Chen & Foley10 |
|
6 | With no control for age or other covariates: All-Cause Mortality Mortality Rate (ref: 6–9h) |
No significant effect. | ||
Data not reported | ||||||
Subjects >=60 years <6h or >9h = 20% 6–9hr = 14.7% |
||||||
Subjects <60 yrs: No Significant Effect | ||||||
Gale & Martyn11 |
|
9 | All-Cause Mortality. RR (ref 9h) <=7h: 1.1 (0.8–1.4) 8h: 0.9 (0.7–1.0) 9h: 1.0 10h: 1.2 (1.0–1.4) 11h: 1.5 (1.2–1.8) >=12h: 1.9 (1.4–2.5) |
All-Cause Mortality RR (ref 9h) <=7h: 1.0 (0.7–1.4) 8h: 0.8 (0.7–1.0) 9h: 1.0 10 h: 1.2 (1.0–1.4) 11 h: 1.3 (1.0–1.7) >=12h: 1.7 (1.2–2.5) |
||
Gottlieb et al.12 |
|
5 | Not Reported | All-Cause Mortality RR (ref 7–8h) |
||
Women | Men | |||||
<6=1.70 | 1.40 | |||||
6= 1.20 | 0.80 | |||||
7–8=1.00 | 1.00 | |||||
9=0.95 | 1.30 | |||||
>9=1.8 | 1.5 | |||||
Hammond6 |
|
0 | Death rate per 100 people lowest for 7 hrs in 17/18 age/gender groups |
|||
Heslop et al.23 |
|
10 | Cardiovascular deaths RR (ref “always 7–8h”) |
Cardiovascular deaths RR (ref “always 7–8h”) |
||
Women | Men | Women | Men | |||
Always <7h: 2.32 (0.99, 5.42) |
1.33 (1.01,1.76) | Always <7h: 2.30 (0.94,5.60) |
1.19 (0.90,1.58) | |||
Always >8h: 1.67 (0.22,1.25) |
0.73 (0.35,15.5) | Always >8h: 1.53 (0.20,1.18) |
0.63 (0.30,13.4) | |||
Increase over time: 0.27 (0.04,2.00) |
0.82 (0.59,1.13) | Increase over time: 0.34 (0.04,2.56) |
0.72(0.52,1.01) | |||
Decrease over time: 1.15 (0.47,2.84) |
1.07 (0.82,1.39) | Decrease over time: 1.34 (0.53,1.25) |
0.88 (0.67,1.16) | |||
All-cause mortality RR (ref 7–8h) |
All-cause mortality RR (ref 7–8h) |
|||||
Always <7h: 1.99 (1.16,3.41) |
1.30 (1.06,1.61) | Always <7h: 1.73 (0.99,3.03) |
1.15(0.99,1.42) | |||
Always >8h: 0.60 (0.08,4.37) |
1.04 (0.65,1.66) | Always >8h: 0.58 (0.08,4.22) |
0.91 (0.57,1.46) | |||
Increase over time: 0.49 (0.20,1.23) |
0.91 (0.72,1.15) | Increase over time: 0.47 (0.19,1.20) |
0.81 (0.64,1.02) | |||
Decrease over time: 0.91 (0.50,1.66) |
1.17 (0.46,1.42) | Decrease over time: 0.98 (0.53,1.79) |
1.00 (0.82,1.21) | |||
Huppert & Whittington13 |
|
Not reported |
All-Cause Mortality RR (Ref 6–9h) |
|||
Women: NS, data not reported | ||||||
Men <6h: 0.95 6–9h: 1.0 >9h: 2.25 | ||||||
Kaplan19 |
|
6 | All-Cause Mortality RR (ref 7–8h) |
|||
Sleeping >7–8 hr or <7–8 hrs Ages 38–49=1.23 (0.88–1.70) Ages 50–59=1.44 (1.08–1.91) Ages 60–69=0.95 (0.73–1.24) Ages >=70=1.05 (0.85–1.29) | ||||||
7–8 hrs per night not associated with different risk ratio vs not sleeping 7- 8 hrs across all groups. | ||||||
Kojima et al.14 |
|
10 | All-Cause Mortality RR (ref 7–8.9h) |
All-Cause Mortality RR (ref:7–8.9h) |
||
Women | Men | Women | Men | |||
<6.9h: 0.92 | 1.90 | <6.9h: 0.90 | 1.93 | |||
(0.53–1.62) | (1.10–3.29) | (0.50–1 61) | (1.12–3.35) | |||
7–8.9h: 1.00 | 1.00 | 7–8.9h: 1.00 | 1.00 | |||
9–9.9h: 1.10 | 1.13 | 9–9.9h: 1.07 | 1.15 | |||
(0.61–2.00) | (0.73–1.74) | (0.58–1.95) | (0.74–1.77) | |||
>=10h: 0.42 | 1.94 | >=10h: 0.40 | 1.77 | |||
(0.06–3.02) | (1.01–3.76) | (0.06–2.92) | (0.88–3.54) | |||
Kripke et al.21 |
|
5 | All-Cause Mortality RR (ref 7–7.9h) |
|||
Women | Men | |||||
<4h: 1.48 | 2.80 | |||||
4–4.9h: 1.40 | 1.59 | |||||
5–5.9h: 1.20 | 1.38 | |||||
6–6.9h: 1.13 | 1.11 | |||||
7–7.9h: 1.00 | 1.00 | |||||
8–8.9h: 1.13 | 1.10 | |||||
9–9.9h: 1.27 | 1.29 | |||||
>=10 h: 1.82 | 1.77 | |||||
Similar trends for Mortality Associated with CHD, stroke, cancer, suicide. Similar trends across multiple age-groups | ||||||
Kripke et al.5 |
|
32 | All-Cause Mortality RR (ref 7 hr) |
|||
Women | Men | |||||
2.5–3.4h: 1.33 | 1.19 | |||||
(1.08–1.64) | (0.96–1.47) | |||||
3.5–4.4h: 1.11 | 1.17 | |||||
(1.01–1.22) | (1.06–1.28) | |||||
4.5–5.4h: 1.07 | 1.11 | |||||
(1.01–1.13) | (1.05–1.18) | |||||
5.5–6.4h: 1.07 | 1.08 | |||||
(1.03–1.11) | (1.04–1.11) | |||||
6.5–7.4h: 1.00 | 1.00 | |||||
7.5–8.4h: 1.13 | 1.12 | |||||
(1.09–1.16) | (1.09–1.15) | |||||
8.5–9.4h: 1.23 | 1.34 | |||||
(1.17–1.28) | (1.28–1.40) | |||||
>=10 h: 1.41 | 1.34 | |||||
(1.34–1.50) | (1.28–1.40) | |||||
Mallon et al.24 |
|
17 | All-Cause Mortality RR (ref 6–8h) |
“Not Significant” Data Not Reported |
||
Women | Men | Similar patterns for mortality associated with coronary artery disease, cancer, and all other causes. |
||||
<6h: 1.0 | 1.1 | |||||
(0.6–1.8) | (0.6–7.0) | |||||
6–8h: 1.0 | 1.0 | |||||
>8h: 1.3 | 2.0 | |||||
(0.6–2.6) | (1.2–3.2) | |||||
Patel et al.15 |
|
11 | All-Cause Mortality RR (ref 7h) <5h: 1.41 (1.25–1.58) 6h: 1.07 (1.00–1.15) 7h: 1.00 8h: 1.18 (1.10–1.26) >=9h: 1.72 (1.55–1.91) |
All-Cause Mortality RR (ref 7h) <5h: 1.08 (0.96–1.22) 6h: 0.99 (0.92–1.06) 7h: 1.00 8h: 1.11 (1.03–1.19) >=9h: 1.40 (1.25–1.55) |
||
ollak et al.16 |
|
10 | All-Cause Mortality Mortality Rate (per 100) |
Cox regression models not significant for Males or females. |
||
Women | Men | Data not available for specific hrs of sleep. | ||||
<=4h: 19 | 24 | |||||
5h: 7 | 25 | |||||
6h: 14 | 16 | |||||
7h: 8 | 16.5 | |||||
8h: 13 | 22 | |||||
>=9h: 18 | 30 | |||||
Qureshi et al.17 |
|
9 | All-Cause Mortality. RR (ref 6–8h) |
|||
6–8h: 1.0 >8h: 1.3 (1.1–1.5) | ||||||
Risk of Stroke RR (ref 6–8 hr) 6–8h: 1.0 >8h: 1.9 (1.2–3.1) | ||||||
Tamakoshi & Ohno8 |
|
14 | All-Cause Mortality RR (ref 7–7.9 hr) |
All-Cause Mortality RR (ref 7–7.9 hr) |
||
Women | Men | Women | Men | |||
<7h: 1.08 | 1.13 | <7h: 1.14 | 1.12 | |||
(0.99–1.17) | (1.04–1.22) | (0.99–1.32) | (0.98–1.28) | |||
7–7.9h: 1.00 | 1.00 | 7–7.9h: 1.00 | 1.00 | |||
8–8.9h: 1.24 | 1.13 | 8–8.9h: 1.20 | 1.18 | |||
(1.14–1.34) | (1.06–1.20) | (1.05–1.38) | (1.06–1.31) | |||
>=9h: 1.64 | 1.52 | >=9h: 1.62 | 1.49 | |||
(1.49–1.80) | (1.42–1.64) | (1.36–1.92) | (1.31–1.70) | |||
Wingard et al.22 |
|
14 | All-Cause Mortality % Mortality (ref 7–8h) |
In multiple logistic analysis with all covariates, sleep had significant independent association with mortality. |
||
Women | Men | |||||
7–8 h: 5.5% | 8.2% | |||||
<=6 h or >=9: 8.8% | 13.6% |
This table is adapted from the summary table previously published by Youngstedt and Kripke1.